Matthew is an associate editor of The American Journal of Managed Care® (AJMC®). He has been working on AJMC® since 2019 after receiving his Bachelor's degree at Rutgers University–New Brunswick in journalism and economics.
Unconscious wakefulness during nighttime sleep, known as cortical arousal, was significantly associated with an increased risk of cardiovascular-related death and death from any cause, with women especially at notable risk.
Women experiencing arousal burden may be at significantly greater risk of cardiovascular (CV)-related death and death from any cause, with men also linked but to a lesser degree, according to study findings published today in the European Heart Journal.
As a normal feature of sleep, the researchers note that unconscious wakefulness, called cortical arousal, occurs spontaneously or is triggered by sleep-disordered breathing and periodic limb movements during sleep, trauma, pain, temperature, light, and traffic noise.
“Arousals, irrespective of the underlying mechanism, impact heart rate, blood pressure, and cardiac hemodynamics acutely, but, when frequent, may also disrupt the circadian rhythm of the CV system, which is associated with unfavorable metabolic profiles, such as higher blood pressure, dysregulated blood lipids, and insulin resistance,” said the study authors.
Hypothesizing that a high arousal burden may be associated with long-term CV and overall mortality, the researchers assessed the prognostic value of a simple index that combined arousal frequency, duration, and total sleep time measured via polysomnograms from 3 studies:
During follow-up of the MrOS study (11.2 [2.1] years), 665 men died, and 236 were CV-related deaths. Furthermore, follow-up for the SOF study (6.4 [1.6] years) saw 105 deaths among women, including 47 CV-related deaths, and there were 987 deaths, including 344 CV-related deaths, reported during the follow-up of the SHHS study (10.7 [3.1] years).
Adjusting for common confounders, including body mass index, apnea-hypopnea index, and smoking, multivariable Cox proportional hazard analysis in female participants experiencing arousal burden that accounted for more than 6.5% of their night's sleep exhibited significant associations with all-cause mortality (SOF: HR, 1.58; 95% CI, 1.01-2.42; P = .038; SHHS-women: HR, 1.21; 95% CI, 1.06-1.42; P = .012) and CV mortality (SOF: HR, 2.17; 95% CI, 1.04-4.50; P = .037; SHHS-women: HR, 1.60; 95% CI, 1.12–2.28; P = .009) compared with women with a lower arousal burden.
For men experiencing arousal burden that accounted for more than 8.5% of their night's sleep, significant associations were shown in the SHHS study for all-cause mortality (HR, 1.31; 95% CI, 1.06-1.62; P = .011) and in the MrOS study for CV mortality (HR, 1.35; 95% CI, 1.02-1.79; P = .034) compared with men with a lower arousal burden.
However, findings for increased risk of death for all-cause mortality in MrOS (HR, 1.11; 95% CI, 0.94-1.32; P = .261) and CV-related death in SHHS (HR, 1.24; 95% CI, 0.86-1.79; P = .271) were not statistically significant.
"It is unclear why there is a difference between men and women in the associations, but there are some potential explanations,” said Dominik Linz, PhD, associate professor in the Cardiology Department at Maastricht University Medical Center, the Netherlands, in a statement. “The triggers causing an arousal or the body's response to arousal may differ in women compared to men. This may explain the relatively higher risk of cardiovascular death in women...Women may have a higher arousal threshold and so this may result in a higher trigger burden in women compared to men."
Researchers said that arousal burden may represent a promising marker to identify mortality risk, with further analysis of frequency of wake periods or sleep stage transitions’ impact on risk suggested.
Shahrbabaki SS, Linz D, Hartmann S, Redline S, Baumert M. Sleep arousal burden is associated with long-term all-cause and cardiovascular mortality in 8001 community-dwelling older men and women. Eur Heart J. Published online April 19, 2021. doi:10.1093/eurheartj/ehab151